145 related articles for article (PubMed ID: 19903040)
1. Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Genazzani AR
Gynecol Endocrinol; 2009 May; 25(5):335-43. PubMed ID: 19903040
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome.
Rossi B; Sukalich S; Droz J; Griffin A; Cook S; Blumkin A; Guzick DS; Hoeger KM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4780-6. PubMed ID: 18812482
[TBL] [Abstract][Full Text] [Related]
3. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance.
Coviello AD; Legro RS; Dunaif A
J Clin Endocrinol Metab; 2006 Feb; 91(2):492-7. PubMed ID: 16249280
[TBL] [Abstract][Full Text] [Related]
4. What is the Risk of Metabolic Syndrome in Adolescents with Normal BMI who have Polycystic Ovary Syndrome?
Aydin Y; Hassa H; Burkankulu D; Arslantas D; Sayiner D; Ozerdogan N
J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):271-4. PubMed ID: 26049937
[TBL] [Abstract][Full Text] [Related]
5. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Syndrome in Adolescents with Polycystic Ovary Syndrome: Prevalence on the Basis of Different Diagnostic Criteria.
Akgül S; Bonny AE
J Pediatr Adolesc Gynecol; 2019 Aug; 32(4):383-387. PubMed ID: 30710625
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.
Apridonidze T; Essah PA; Iuorno MJ; Nestler JE
J Clin Endocrinol Metab; 2005 Apr; 90(4):1929-35. PubMed ID: 15623819
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS.
Carmina E; Napoli N; Longo RA; Rini GB; Lobo RA
Eur J Endocrinol; 2006 Jan; 154(1):141-5. PubMed ID: 16382003
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
Hahn S; Tan S; Sack S; Kimmig R; Quadbeck B; Mann K; Janssen OE
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):130-5. PubMed ID: 17318774
[TBL] [Abstract][Full Text] [Related]
11. Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome.
Leibel NI; Baumann EE; Kocherginsky M; Rosenfield RL
J Clin Endocrinol Metab; 2006 Apr; 91(4):1275-83. PubMed ID: 16449341
[TBL] [Abstract][Full Text] [Related]
12. Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients.
Albu A; Radian S; Fica S; Barbu CG
Endocrine; 2015 Mar; 48(2):696-704. PubMed ID: 25022659
[TBL] [Abstract][Full Text] [Related]
13. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
14. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
Alemzadeh R; Kichler J; Calhoun M
Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
[TBL] [Abstract][Full Text] [Related]
16. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
Li L; Chen X; He Z; Zhao X; Huang L; Yang D
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
[TBL] [Abstract][Full Text] [Related]
17. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
18. Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels.
Fruzzetti F; Perini D; Lazzarini V; Parrini D; Genazzani AR
Fertil Steril; 2009 Aug; 92(2):626-34. PubMed ID: 18706545
[TBL] [Abstract][Full Text] [Related]
19. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
20. The incidence of metabolic syndrome in adolescents with different phenotypes of PCOS.
Altintas KZ; Dilbaz B; Cirik DA; Ozelci R; Zengin T; Erginay ON; Dilbaz S
Ginekol Pol; 2017; 88(6):289-295. PubMed ID: 28727126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
